Clavulanic acid is a beta-lactamase inhibitor used in therapeutic combinations with the penicillin-type antibiotics. During the fermentation leading to clavulanic acid, a succinyl L-tyrosine by-product is unavoidably formed. Occasionally, the amount of this by-product is found to be as high as 2% of the product even after standard purification operations. To further remove this impurity, we prepared a highly specific adsorbent for succinyl L-tyrosine with the molecular imprinting technique. This was performed by simultaneously using vinylbenzyl trimethylammonium chloride and methacrylic acid as the functional monomers. The imprinted polymer selectively bound succinyl L-tyrosine, and could be successfully used to remove this impurity at concentrations of less than 2% in the presence of clavulanic acid.

Download full-text PDF

Source
http://dx.doi.org/10.1002/bit.10271DOI Listing

Publication Analysis

Top Keywords

succinyl l-tyrosine
16
clavulanic acid
16
beta-lactamase inhibitor
8
imprinted polymer
8
remove impurity
8
acid
5
removal fermentation
4
fermentation by-product
4
succinyl
4
by-product succinyl
4

Similar Publications

Amino acids, UPLC-MS phenolic metabolites and multivariate approach for elucidating the effect of two growing conditions on growth and yield attributes in okra pods and leaves.

Food Chem

November 2024

Green Biotechnologies Research Centre of Excellence, Faculty of Science and Agriculture, University of Limpopo, Private Bag X1106, Sovenga, Limpopo 0727, South Africa. Electronic address:

Okra is one of the highly nutritious indigenised food crops in Southern Africa. The study intended to evaluate plant growth, yield, amino acids, and untargeted semi-targeted phenolic metabolites grown concurrently at greenhouse and micro-plot under open-field conditions. Yield and growth attributes: stem diameter, plant height, number of branches per plant, number of pods per plant, pod weight, pod length and pod diameter were higher in the micro-plot under open-field conditions.

View Article and Find Full Text PDF

Background: Sirtuin 7 (SIRT7) is pivotal in diverse diseases progression. Importantly, SIRT7 is associated with melanin production. However, whether SIRT7 regulates vitiligo is unclear.

View Article and Find Full Text PDF

The present study aimed to explore the similarity and difference in taste enhancement properties of N-succinyl-L-phenylalanine (N-Suc-Phe), N-succinyl-L-tryptophan (N-Suc-Trp), and N-succinyl-L-tyrosine (N-Suc-Tyr) using temporal dominance of sensations (TDS), temporal check-all-that-apply (TCATA), and time-intensity (TI) techniques. Meanwhile, leading taste enhancers in the market, such as N'-[(2,4-dimethoxyphenyl)methyl]-N-(2-pyridin-2-ylethyl) oxamide (DE) was chosen to conduct a comparative analysis with the aforementioned three compounds. Findings from TDS and TCATA revealed that all compounds under investigation notably enhanced umami and saltiness while reducing bitterness in a concentration-dependent fashion (0.

View Article and Find Full Text PDF

SUCLG1 restricts POLRMT succinylation to enhance mitochondrial biogenesis and leukemia progression.

EMBO J

June 2024

Precision Research Center for Refractory Diseases, Institute for Clinical Research, Shanghai Key Laboratory of Pancreatic Disease, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, 200080, Shanghai, China.

Article Synopsis
  • Mitochondria are like tiny power plants in our cells that create energy, and they rely on special proteins to do this job.
  • A key enzyme called SUCLG1 helps control these proteins by managing a substance called succinyl-CoA, which affects the way another important protein, POLRMT, works with mitochondrial DNA.
  • In leukemia, certain mutations can boost SUCLG1 levels, improving mitochondrial production and helping cancer cells grow, but reducing SUCLG1 or POLRMT can slow down the disease.
View Article and Find Full Text PDF
Article Synopsis
  • - Hepatorenal tyrosinemia type 1 (HT-1) is a rare genetic disorder caused by a deficiency in the enzyme fumaryl acetoacetate hydrolase, leading to toxic metabolite buildup that can harm the liver, kidneys, and nervous system.
  • - The introduction of the drug NTBC (nitisinone) has greatly enhanced HT-1 management when treatment begins early, alongside the importance of newborn screening for timely diagnosis.
  • - Patients require regular monitoring of liver and kidney function, and those who do not respond to treatment may need a liver transplant; they are also at risk for long-term neurocognitive issues, necessitating ongoing assessments and therapies.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!